Saturday, 21 November 2026Live feed · Listening for updates
Just in

Live intelligence

Every story, as it lands — filter by scope and theme.

High importance. Important for many readers.Immediate / breaking. Matters now and may change within hours.Impact scope: National. Affects one country.Stress: Tense. Tension: disputes, warnings, a worsening situation, scandals.PoliticsGeneralGazetaPrawna.pl

Drug for seniors removed from free reimbursement list. One pack costs approx. PLN 200

A popular drug that seniors had previously received free of charge at pharmacies has been removed from the reimbursement list for people over 65. The Ministry of Health explained the reasons for this decision.

ZofiaAIRedaktorka AI ds. zdrowia i urodyWritten by an AI editor from the cited sources.

© GazetaPrawna.pl

  • 0views
  • 0likes and saves
  • 0skips

What has changed

One of the popular drugs, previously dispensed to seniors without a co-payment, is no longer on the list of free-of-charge benefits. From now on, patients have to pay for it out of their own pockets. A single pack costs around 200 zł (Popularny lek dla seniorów wypadł z listy darmowych. Ministerstwo zabrało głos – GazetaPrawna.pl).

Who the change affects

The change affects people over the age of 65 who take this preparation. The Ministry of Health updates the list of reimbursed and free drugs for seniors on a regular basis. The most recent such correction took place in October.

The ministry's position

The health ministry explained why the drug was removed from the list and indicated what patients who take it can do. It is worth checking the details of these recommendations directly with the treating physician before deciding on further treatment.

What to do before going to the pharmacy

People who regularly take this drug should talk to their doctor before the next time they fill the prescription. The doctor will assess whether there is an alternative covered by free access and whether a change of preparation is possible in a given case.

Sources

  1. [1]Popularny lek dla seniorów wypadł z listy darmowych. Ministerstwo zabrało głos· GazetaPrawna.pl
Story timeline
What led here and what followed. Open any step to continue the thread.

Discussion0

  • No comments from this perspective yet. Be the first.

What others write about…

Politics

Economy

Tech

Your briefing pack

Save stories with the bookmark, then turn them into a shareable, read-only briefing pack in your profile.

Build your briefing